Rapid advancement in glucose control has long been affiliated with a temporary worsening of diabetic retinopathy. Mounjaro has not been studied in patients with non-proliferative diabetic retinopathy requiring acute therapy, proliferative diabetic retinopathy, or diabetic macular edema. The AMA does circuitously or indirectly exercise medicine or dispense clinical services. The https://daveyu988jzo5.newbigblog.com/profile